Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibody therapy for chronic lymphocytic leukemia.

Seminars in hematology - 1 Apr 2008

Christian Beth A, Lin Thomas S

Abstract excerpt

The introduction of the monoclonal antibodies rituximab (anti-CD20) and alemtuzumab (anti-CD52) has revolutionized the treatment of chronic lymphocytic leukemia (CLL). Both antibodies were first studied as single agents in relapsed CLL, but rituximab is increasingly used in combination chemoimmunotherapy regimens in previously untreated patients. Phase II studies demonstrated that the addition of rituximab to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Antibodies, Monoclonal, Murine-Derived
Share to Antibodies, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Drugs, Investigational

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Rituximab

Share to Vidarabine

Source

Open in PubMed Open full text

Identifiers

PMID: 18381104
DOI: 10.1053/j.seminhematol.2008.02.001
PMCID: PMC2390995

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibody therapy for chronic lymphocytic leukemia.PMID 18381104Read ↗

Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies.Semantic proximity Read ↗

Update on therapy of chronic lymphocytic leukemia.Semantic proximity Read ↗

Recent therapeutic advances in chronic lymphocytic leukemiaSemantic proximity Read ↗

Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.Semantic proximity Read ↗

Chronic lymphocytic leukaemia.Semantic proximity Read ↗

Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.Semantic proximity Read ↗

Chronic lymphocytic leukemia: a clinical review including Korean cohorts.Semantic proximity Read ↗

Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia: Current Concepts.Semantic proximity Read ↗

Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphoma.Semantic proximity Read ↗

Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.Semantic proximity Read ↗

[Chronic lymphocytic leukemia : treatment concepts in transition].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.